ClinicalTrials.Veeva

Menu

Virtual Reality-Supported Cardiac Rehabilitation: Psychological, Functional, and Physiological Perspectives

W

Wroclaw University of Health and Sport Sciences

Status

Active, not recruiting

Conditions

Coronary Arterial Disease (CAD)
Myocardial Disease
Cardiovascular Diseases
Heart Disease

Treatments

Behavioral: Cardiac rehabilitation
Device: Virtual Reality Therapy

Study type

Interventional

Funder types

Other

Identifiers

NCT06896318
54/2024

Details and patient eligibility

About

The study aims to evaluate the effectiveness of virtual reality-assisted cardiac rehabilitation compared to conventional cardiac rehabilitation in improving psychological outcomes-depression, stress, anxiety, and kinesiophobia-along with physiological parameters, functional status, physical activity levels, and quality of life in cardiac patients.

Full description

This single-blind randomized controlled trial will include 60 participants aged 60 years and older undergoing Phase II CR at the Provincial Specialist Hospital of the Blessed Virgin Mary in Częstochowa, Poland. Participants will be randomly assigned to one of two groups: a conventional CR program or a VR-CR group. Both groups will complete a three-week hospital-based CR program involving structured group exercises, interval cycling, and relaxation sessions. The experimental group will additionally receive eight sessions of immersive VR therapy using the VRTierOne device, consisting of 20-minute sessions twice weekly. These sessions employ interactive and calming virtual environments to promote relaxation and psychological engagement. Outcome measures will be evaluated at baseline (week 0), post-intervention (week 3), and follow-up (week 7). Assessments will include Patient-Reported Outcome Measures for stress, depression, kinesiophobia, and quality of life, physiological metrics (heart rate, blood pressure, metabolic equivalents), HRV, functional capacity (6MWT), and physical activity levels measured using the pedometers.

Enrollment

60 estimated patients

Sex

All

Ages

60 months to 85 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • cardiovascular diseases (atherosclerosis, hypertension, coronary artery disease, ischemic heart disease, peripheral artery disease, rheumatic heart disease, deep vein thrombosis, pulmonary embolism, and post-myocardial infraction)
  • the second stage of cardiac rehabilitation conducted in outpatient settings

Exclusion criteria

  • Severe psychiatric disorders (e.g., psychotic symptoms, bipolar disorder)
  • initiation of psychiatric treatment or individual psychological therapy during the study period
  • current use of antidepressant medications
  • cognitive impairments that hinder questionnaire completion, consciousness disorders
  • sensory impairments (e.g., severe visual or auditory deficits) that limit interaction with virtual reality.

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Single Blind

60 participants in 2 patient groups

VR Group
Experimental group
Description:
Cardiac rehabilitation supplemented by VR therapy
Treatment:
Device: Virtual Reality Therapy
Behavioral: Cardiac rehabilitation
Control Group
Active Comparator group
Description:
Conventional cardiac rehabilitation
Treatment:
Behavioral: Cardiac rehabilitation

Trial contacts and locations

2

Loading...

Central trial contact

Błażej Cieślik, PhD.

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems